FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome ...Middle East

Medscape - News
The synthetic vasopressin analogue is an injectable medication indicated for patients with hepatorenal syndrome who are experiencing rapid deterioration of kidney function (type 1 hepatorenal syndrome). FDA Approvals

Hence then, the article about fda okays terlipressin terlivaz for hepatorenal syndrome was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome )

Apple Storegoogle play

Last updated :

Also on site :